Our findings also suggest that mutations in the DYN1 region of DYNC1H1 may be correlated with more severe clinical phenotypes, more complicated manifestations, and more common CNS involvement, which may shed light on unraveling the genetic mechanism underlying clinical heterogeneity of “dyneinopathy.” The gene discussed is DYNC1H1; the disease is dyneinopathy.